TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies and its investigational immunotherapeutic to transform treatment for patients with…
Quadria Capital, Asia’s premier healthcare-focused private equity firm, today announced the final close of its Fund III with US$1.07 billion in total commitments, significantly exceeding its original $800 million target.…
AriBio and Fujirebio Reach Key Milestone in Alzheimer’s Biomarker Research with Completion of Sample Collection from Phase 3 Trial Fujirebio Holdings Inc., along with its wholly owned subsidiary Fujirebio Diagnostics,…
CVS Pharmacy: Bringing Personalized Care to Communities with New Small Format Stores In a rapidly evolving health care landscape, one thing remains constant: the importance of trusted, accessible, and personalized…
Vasomune Therapeutics to Present Late-Breaking Research on AV-001 at the 2025 American Thoracic Society International Conference Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to address diseases driven…
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported robust financial and operational results for the first quarter of 2025, underscoring the company’s continued momentum and strategic focus on advancing its late-stage…
Twist Bioscience Spins Out DNA Data Storage Platform into New Independent Company, Atlas Data Storage Twist Bioscience Corporation (NASDAQ: TWST), a leading and innovative company operating in the mid-cap growth…
Henry Schein Reports Strong First Quarter 2025 Financial Results, Reaffirms Full-Year Guidance Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions for office-based dental and medical practitioners,…
ImmunityBio Requests Urgent FDA Meeting After Refusal to File sBLA for ANKTIVA in NMIBC Papillary Disease, Citing Sudden Reversal from January Guidance ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company…
Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants…
TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in…
Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official…